Influenzavirus B Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 100 pages | ID: I6413EEA9E28EN
VPAResearch

Abstracts

Influenzavirus B Infections Drug pipeline report- 2020 is an annual R&D review of Influenzavirus B Infections pipeline candidates. The report presents the current status of all major Influenzavirus B Infections therapeutic compounds. Detailed insights into Influenzavirus B Infections pipeline development, current status, companies, drug profiles and Influenzavirus B Infections preclinical and clinical trials are included.

2020 Influenzavirus B Infections Pipeline Market Insights
Influenzavirus B Infections disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Influenzavirus B Infections therapies, pipeline by phase and others are included.

Influenzavirus B Infections pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Influenzavirus B Infections Therapeutic Drug candidates
Both active and inactive Influenzavirus B Infections pipeline drug candidates are included in the report

Influenzavirus B Infections Clinical Trials and preclinical Studies
Influenzavirus B Infections In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Influenzavirus B Infections pipeline market developments
Influenzavirus B Infections Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Influenzavirus B Infections pipeline companies in active development
The report analyzes Influenzavirus B Infections pipeline of the below companies-

AbbVie Inc, Adimmune Corp, Altravax Inc, Amarillo Biosciences Inc, Aphios Corp, AstraZeneca Plc, AusBio Ltd, Biotron Ltd, Cocrystal Pharma Inc, ContraFect Corp, Daiichi Sankyo Co Ltd, Evotec AG, GC Pharma, GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc, iQur Ltd, Medicago Inc, MedImmune LLC, Novavax Inc , Romark Laboratories LC, Sanofi, Seqirus Ltd , Shionogi & Co Ltd, SK Bioscience, Vacthera BioTech GmbH, Vaxart Inc, Viramatix Sdn Bhd

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
27 Companies investing in Influenzavirus B Infections pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Influenzavirus B Infections pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. INFLUENZAVIRUS B INFECTIONS PIPELINE MARKET INSIGHTS, 2020

1.1 Influenzavirus B Infections Disease Overview
1.2 Influenzavirus B Infections Drug Pipeline Snapshot, 2020
  1.2.1 Influenzavirus B Infections Pipeline Drugs by Phase
  1.2.2 Influenzavirus B Infections Pipeline Drugs by Company
  1.2.3 Influenzavirus B Infections Pipeline Drugs by Mechanism of Action
  1.2.4 Influenzavirus B Infections Pipeline Drugs by Route of Administration

2. INFLUENZAVIRUS B INFECTIONS COMPANY WISE PIPELINE DETAILS

AbbVie Inc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Adimmune Corp Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Altravax Inc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Amarillo Biosciences Inc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Aphios Corp Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
AstraZeneca Plc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
AusBio Ltd Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Biotron Ltd Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cocrystal Pharma Inc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
ContraFect Corp Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Daiichi Sankyo Co Ltd Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Evotec AG Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
GC Pharma Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Inovio Pharmaceuticals Inc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
iQur Ltd Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Medicago Inc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
MedImmune LLC Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Novavax Inc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Romark Laboratories LC Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sanofi Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Seqirus Ltd Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Shionogi & Co Ltd Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
SK Bioscience Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vacthera BioTech GmbH Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vaxart Inc Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Viramatix Sdn Bhd Influenzavirus B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. INFLUENZAVIRUS B INFECTIONS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. INFLUENZAVIRUS B INFECTIONS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts